MedTrace Logo

Diagnostic of Puumala Virus Infection in France

NCT02455375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179

Last updated 2023-08-25

No results posted yet for this study

Summary

Routine Puumala virus (PUUV) infection diagnosis is performed using serological commercial kits of which performances have not been established in real life, which use recombinant protein from strains from Central or North Europe. Molecular diagnostic of these infection is not the rule. Consequently the objectives of the project are to evaluate the performances of the serological commercial assays in real life in France and to assess the use of urine versus plasma for the molecular diagnostic of this infection.

Conditions

  • Nephropathia Epidemica
  • Hemorrhagic Fever With Renal Syndrome

Sponsors & Collaborators

  • Institut Pasteur

    collaborator INDUSTRY

  • Centre Hospitalier de Charleville-Mézières

    lead OTHER

Principal Investigators

  • Jean Marc Galempoix, MD · CH de Charleville-Mézières

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2021-11-30
Completion
2021-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02455375 on ClinicalTrials.gov